Global HPV and pap smear test market to hit $3.94b by 2030

The sector’s expansion is attributed to the rising number of HPV cases.

The global Human Papillomavirus (HPV) and Pap smear test market is expected to reach $3.94b by 2030 at a compound annual growth rate of 10%, according to MarketsandMarkets.

The sector’s expansion is attributed to the rising number of HPV cases, which is closely linked to an increasing incidence of cervical cancer.

“The growing awareness of cervical cancer screening programmes, supported by government initiatives and healthcare organisations, has encouraged more women to undergo routine tests, further boosting market adoption,” the report said.

Moreover, increased research and development funding for cervical cancer prevention is driving market growth.